Chaoying Gu

Dr. Chaoying Gu

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZQZhuoqiong Qiu
Zhuoqiong Qiu
ZZZhenlai Zhu
Zhenlai Zhu
XLXiaochun Liu
Xiaochun Liu
BCBaichao Chen
Baichao Chen
HYHuibin Yin
Huibin Yin
WLWei Li
Wei Li
Microbial dysbiosis in the skin has been implicated in the pathogenesis of atopic dermatitis (AD); however, whether and how changes in the skin microbiome initiate skin inflammation, or vice versa, remains poorly understood. Here, we report that the levels of sebum and its microbial metabolite, propionate, were lower on the skin surface of AD patients compared with those of healthy individuals. Topical propionate application attenuated skin inflammation in mice with MC903-induced AD-like dermatitis by inhibiting IL-33 production in keratinocytes, an effect that was mediated through inhibition of HDAC and regulation of the AhR signaling pathway. Mice lacking sebum spontaneously developed AD-like dermatitis, which was improved by topical propionate application. A proof-of-concept clinical study further demonstrated the beneficial therapeutic effects of topical propionate application in AD patients. In summary, we have uncovered that the dysregulated sebum–microbial metabolite–IL-33 axis might play an initiating role in AD-related skin inflammation, thereby highlighting novel therapeutic strategies for the treatment of AD.

18 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CGChaoying Gu
Chaoying Gu
XYXu Yao
Xu Yao
WLWei Li
Wei Li
Atopic dermatitis (AD) is now a global health problem and has been attracting extensive attention from both academic and public society in China. This review aimed to present the current status of the prevalence, disease burden, clinical features, diagnosis, and management of AD in China. The prevalence of AD has been increasing rapidly in China during the past decades, partially due to the increased recognition of the disease; there are still substantial amounts of over-diagnosed eczema and under-diagnosed AD. Chinese dermatologists see many AD patients with atypical manifestation, which poses a challenge to the diagnosis. The Chinese diagnostic criteria for adults and pediatric patients with AD have been proposed respectively and validated with high sensitivity and specificity. International and Chinese guidelines for management of AD have been popularized; however, there are still many practices that need verification through randomized case-control study. Dupilumab and JAK inhibitors have demonstrated favorable efficacy for AD patients in China, and a multidimensional approach is needed for selection of the patients and evaluation of the efficacy and safety. Patient education and long-term management for AD are just beginning in China, and need to be strengthened in the future.

1 June 2005 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
ZZZheng-hua Zhang
Zheng-hua Zhang
WHWei Huang
Wei Huang
ZNZhenmin Niu
Zhenmin Niu
WLWei-Da Liu
Wei-Da Liu
LXLeihong Xiang
Leihong Xiang
ZZZhi-Zhong Zheng
Zhi-Zhong Zheng

19 March 2026 in International Journal of Dermatology
Verified
Journal Article
Open access
BHBruno Halioua
Bruno Halioua
JTJerry Tan
Jerry Tan
CGChaoying Gu
Chaoying Gu
TLThomas Luger
Thomas Luger
JSJulien Seneschal
Julien Seneschal
JSJonathan I. Silverberg
Jonathan I. Silverberg

27 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ZLZheng Li
Zheng Li
HYHuibin Yin
Huibin Yin
YWYu Wang
Yu Wang
SWShangshang Wang
Shangshang Wang
YWYuemeng Wu
Yuemeng Wu
WLWei Li
Wei Li
Background/Objective: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by diverse clinical manifestations. However, variations in its clinical presentations across different ages, genders, anatomical sites, and seasons remain incompletely understood. The objective was to explore the clinical heterogeneities of AD using data from the Chinese non-selective registration system. Methods: A prospective analysis was conducted on 3829 AD patients enrolled in the Chinese Non-selective Registry for AD (CNRAD) at hospital settings from 2020 to 2022. Demographic profiles; distribution, type, and severity of the skin lesion; laboratory findings; allergic comorbidities; family history; and exacerbating factors were analyzed. Results: The male-to-female ratio was 0.92 among adolescent and adult AD patients but increased to 2.11 in elderly AD patients, highlighting an age-dependent gender difference in AD prevalence. Age groups displayed distinct anatomical preferences for lesion distribution, with reduced involvement of the cubital and popliteal fossae in adult and elderly patients. Based on skin lesion characteristics, ten clinical subtypes of AD were proposed. Elderly AD patients exhibited higher severity, compared to adolescence and adult AD patients, with male patients being more severe than females. Elderly AD patients showed a lower proportion of extrinsic type, compared to childhood AD patients. Seasonal change emerged as the most important factor triggering AD flares. Conclusions: This study provides new insights into the heterogeneities of AD clinical manifestations in the Chinese population, demonstrating their significant dependence on temporal factors, including age and season.

7 March 2025 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YWYu Wang
Yu Wang
HYHuibin Yin
Huibin Yin
ZLZheng Li
Zheng Li
HWHao Wu
Hao Wu
QWQianhao Wang
Qianhao Wang
WLWei Li
Wei Li